Actor portrayals Our promise Learn about our promise and what we are doing to protect patient safety
Many providers recommend reassessing your plan every 3 months during the first year, checking in on weight progress, appetite control, side effects, and any changes in your metabolic blood work
Wegovy and Zepbound are specifically approved for weight management, which simplifies this particular issue, but doesn't eliminate the other hurdles
Most patients begin with 2.5 mg weekly for the first month, then increase to 5 mg weekly
This unique presentation of both NAWE and TIND in a single patient following GLP-1 agonist use warrants careful consideration of the potential central and peripheral neurological sequelae of these increasingly prevalent medications and emphasizes the need for heightened clinical awareness and appropriate monitoring strategies
Instead, the SSA looks at how much your symptoms limit your ability to work